David Dieter
Executive VP, General Counsel & Corporate SecretaryMr. David Dieter is Executive VP, Secretary & General Counsel of Collegium Pharmaceutical, Inc. from March 2025. He formerly served as Vice President, Legal at Horizon Therapeutics (acquired by Amgen in October 2023), where he managed internal and external counsel and served as advisor to executive leadership across business functions on corporate and commercial matters. Prior, as Associate General Counsel, Mr. Dieter played a key role in Horizon's mergers, acquisitions and dispositions. Before Horizon, Mr. Dieter held several leadership roles at Takeda, including Vice President, Government Affairs and Associate General Counsel for Commercial Law. He was a Partner at Freeborn & Peters, Smith Gambrell Russell and an Associate at Perkins Coie. He received a B.A. in Economics from the University of Tennessee, Knoxville and a J.D. from the University of Illinois College of Law, Champaign.
Positions
- Company NameCollegium Pharmaceutical, Inc.Stock CodeCOLLPositionExecutive VP, General Counsel & Corporate SecretaryColleagues
- VKVikram KarnaniCEO, President & Director
- GSGino SantiniIndependent Chairman
- CTColleen TupperExecutive VP & CFO
- TBThomas B. SmithExecutive VP & Chief Medical Officer
- IKIan KarpHead of Investor Relations
- GGGaren G. BohlinIndependent Director
- RJRita J. Balice-GordonIndependent Director
- NSNancy S. LurkerIndependent Director
